An exosome service page is the riskiest page on most regen websites. The science is new. The rules are strict. And the wrong word can draw FDA attention. This guide covers exosome service page structure and the FDA limits that shape it. You will get the exact page framework, not just a list of rules.
TLDR: A compliant exosome service page structure follows six sections in order. They lead with science and end with a consultation. There are no FDA-approved exosome products. That fact belongs in the body of the page, not the footer. Disclaimers go at the top and again next to the clinical content. Swap every outcome claim for a plain note on what exosomes are. Get the structure right, and the page earns trust without a warning letter.
Important Note This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing company, not a law firm or compliance consultancy.
Most regen clinics know the basic exosome rules by now. You cannot say exosomes heal. You cannot promise results. But knowing the rules is not the same as building the page. That gap is where clinics get into trouble.
I have seen good clinics break the rules without meaning to. The copy describes a treatment that repairs tissue. The legal status sits in tiny footer text, if it shows up at all. The disclaimers are buried below the fold. None of it is on purpose. It is just bad structure.
This post fixes the structure. Other guides tell you what you can and cannot say. This one shows you how to build the page. We go section by section. The words land in the right order. The compliance pieces sit where they belong.
Why Exosome Service Pages Carry More Risk Than Other Regen Pages
Exosome pages carry more risk because no exosome product is FDA-approved. That is the key difference. A PRP page can lean on a real FDA clearance for bone graft handling. An exosome page has no approval to stand on.
The FDA has been clear about this. There are no FDA-approved exosome products for any human use. The agency has warned the public about clinics that sell them as treatments. You can read the FDA’s public safety notification on exosome products yourself. Market an unapproved product as a treatment, and the FDA can treat it as an unapproved drug.
That raises the stakes for every word. A stem cell page has its own limits. But cord-blood products at least have an approved lane. An exosome page does not. So the structure has to do more work. It must keep the page teaching, not selling. For the wider view, see our breakdown of exosome marketing rules.
What this means for your practice: Treat the exosome page as your highest-risk page. Build it with extra care. It has no FDA approval to fall back on.
The Six Required Sections Of A Compliant Exosome Service Page
A compliant exosome page follows six sections, in order. The order matters. It leads with science. It moves through process and legal status. It ends with a consultation invite. Here is each section and what goes in it.
Section 1: What Exosomes Are
Open with the science, not a sales pitch. Describe exosomes as tiny vesicles studied for their role in cell signaling. Keep it factual. Do not say what they do for a patient. Just explain what they are.
Section 2: How The Procedure Works At This Clinic
Describe the process in plain terms. Walk through the steps a patient would take. Focus on what happens, not on a result. This answers what is involved, never what someone will get.
Section 3: Current Regulatory Status
State plainly that there are no FDA-approved exosome products. Put this in the body, in clear text. Every reader should see it. This is the most important section on the page. Our guide to the FDA stance on exosome products shows the exact words to use.
Section 4: Who The Consultation Is For
Describe who tends to book a consultation. Use plain terms, not a condition list. Do not name diseases the process treats. Describe the kind of person who wants to learn more. A condition list reads like a treatment claim. A plain note does not.
Section 5: What To Expect In The Consultation
Frame the next step as a talk, not a booking. The consultation covers what the process involves and what research suggests. Keep the pressure low. The goal is an informed talk, not a hard sell.
Section 6: Disclaimers
Close with clear disclaimers. Place them near the clinical content above, not only in the footer. State again that the content is educational. State again that no exosome products are FDA-approved. This section seals the page.
What this means for your practice: Follow the six sections in order. The structure keeps the page clean. It forces science and legal status to come before any consultation invite.
The Language Swap: Outcome Claims To Compliant Descriptions
Every outcome claim on the page needs to become a plain note. The swap is the line between a page that draws FDA risk and one that does not. Here are the common claims and their compliant swaps.
| Non-Compliant | Compliant |
|---|---|
| “Exosome therapy rejuvenates damaged tissue” | “Exosomes are extracellular vesicles studied for their role in cell-to-cell communication and tissue signaling” |
| “Patients experience faster recovery” | “The consultation covers what the procedure involves and what the current research suggests” |
| “Our protocol is effective for joint inflammation” | “Some patients inquire about exosome procedures in the context of joint conditions, the consultation is the appropriate place to discuss your situation” |
| “FDA-approved exosome therapy available” | “There are currently no FDA-approved exosome products. We explain what that means for our approach in consultations.” |
| “Most patients see improvement within weeks” | “We invite a consultation to discuss whether this procedure may be appropriate for your situation” |
| “Exosome treatment repairs tissue naturally” | “The research on exosome mechanisms is ongoing; the consultation covers what is currently understood” |
What this means for your practice: Run a find-and-replace on your draft. Any line that promises a result must become a note about the science or the consultation. No exceptions.
Where Disclaimers Go On The Page
Disclaimers belong near the claims they support, not in the footer. A disclaimer ten scrolls down does not protect you. Place it where the reader sees it.
For an exosome page, use two spots at least. Put one near the top to frame the page. Put another inline, next to the procedure description and the legal status. The footer can hold a third. But the footer alone is not enough. The reader should never reach a treatment description without a disclaimer nearby.
One more detail. Keep any contact form general, not condition-based. That keeps you clear under HIPAA. A form that asks about a health condition can pull private data into your tools.
This rule is a trust signal too. Pages that hide disclaimers read as shady. Pages that show them read as honest. For more on a page people trust, see our work on website design for regen clinics and the trust signals that matter most.
What this means for your practice: Place a disclaimer at the top and again next to the clinical content. Keep the contact form general. Do not let the footer carry the legal weight.
What Internal Links This Page Needs And Why
An exosome page should link to pages that give it context. The right links do two things. They help the reader learn the rules. And they tell Google your site has real depth.
Three links matter most. Link to your exosome marketing rules, so readers see the wider picture. Link to your classification explainer. The 361 versus 351 framework is why exosomes sit where they do. And link to your broader claims guidance, like our overview of what regen clinics can and cannot say. Each link adds context.
What this means for your practice: Link the page to your classification and marketing-rules pages. The links build context for the reader and authority for your site.
What The FDA’s Position Means For Your Page
The FDA’s stance shapes every choice on the page. Your words set a product’s intended use in the FDA’s eyes. Hint that the process treats a disease, and the FDA can class the product as an unapproved drug.
That is why the legal status section is not optional. It is the page’s anchor. The FDA’s tissue and tissue products page explains how human cell and tissue products are grouped. Most exosome products fall outside the narrow group that skips premarket review. That is why they are unapproved. Your page should reflect that, not hide it.
What this means for your practice: Your words set the product’s intended use. Keep the copy in teaching framing. Keep the legal status front and center.
How This Looks In Practice
Picture a clinic in the Midwest. It is rewriting an exosome page that had been live for a year. Here is how they might rebuild it.
The Challenge: The old page called the service exosome therapy that heals joints faster. It listed several conditions by name. The only disclaimer sat in the footer, in small text. The legal status was not mentioned at all.
The Approach: The clinic rebuilt the page into the six sections. They opened with the science. They described the process in plain terms. They added a clear legal status section in the body. They swapped the condition list for a plain note.
The Compliance Check: They turned every outcome claim into a note, using the table above. They stated plainly that no exosome products are FDA-approved. They placed disclaimers at the top and inline, not just in the footer.
The Result: The page read as honest teaching, not a sales pitch. Skeptical cash-pay researchers trusted it more. It did not overpromise. And there was nothing on the page for the FDA to flag.
Frequently Asked Questions
Do I have to say there are no FDA-approved exosome products on my exosome page? Yes. That fact belongs in the body, in clear text. Leaving it out, or hiding it in the footer, is a fast way to draw FDA risk. State it plainly in the legal status section.
Where should the legal status go, the footer or the body? The body. A legal status buried in the footer does not do its job. Put it in its own section. Every reader should see it first.
Can I describe what exosomes do? You can describe what exosomes are, as tiny vesicles studied for their role in cell signaling. You cannot describe what they do for a patient. That becomes an outcome claim. Stick to biology, not benefit.
Can I list the conditions patients ask about? Skip the condition list. Naming diseases the process treats reads like a treatment claim. Instead, describe in plain terms the kind of person who reaches out.
Do I need a disclaimer at the top and again inline? Yes. One at the top frames the page. A second sits next to the clinical content. The footer alone is not enough.
Can I put testimonials on an exosome service page? Only with care. Any testimonial must be real, disclose paid ties, and avoid outcome or cure claims. On an exosome page, a testimonial that hints at a result is risky. No exosome product is approved. Follow the FTC’s endorsement guides closely.
Should the exosome page link to my other regen pages? Yes. Link to your exosome marketing rules, your classification explainer, and your broader claims guidance. These links give the reader context and build authority for your site.
Key Takeaways
- Exosome pages carry more risk because no exosome product is FDA-approved.
- Structure the page in six sections that lead with science and end with a consultation.
- Put the FDA legal status in the body of the page, not the footer.
- Describe exosomes by their biology, never by an outcome they produce.
- Swap condition lists for a plain line on who the consultation serves.
- Place disclaimers at the top and again next to the clinical content.
- Link the page to your classification and exosome-marketing pages for context.
Your Next Step
PS: An exosome service page built on the right structure earns trust from skeptical cash-pay researchers and keeps the FDA out of your inbox. Reach out at [email protected], or watch how we approach regen service page compliance on YouTube at https://www.youtube.com/@oatellez.
Compliance Disclaimer This article is educational and does not constitute legal, medical, or regulatory advice. It reflects publicly available information that can change as regulations, enforcement priorities, and platform policies evolve. It does not promise any marketing outcome or specific compliance result. Before acting on anything here, have your own marketing reviewed by qualified legal counsel familiar with FDA, FTC, HIPAA, and the advertising rules in your state.
About Regen Portal: Regen Portal is a marketing company serving the regenerative medicine industry. We provide SEO, content creation, social media management, paid advertising, website development, and branding services for clinics, manufacturers, distributors, and independent providers. Some strategies discussed in our educational content align with services we offer. For more on how we work, contact us.
About Oscar Tellez: Oscar Tellez is the founder of Regen Portal, a marketing company built for the regenerative medicine industry. With over 15 years of experience spanning clinical operations, product distribution, and digital marketing, Oscar has helped hundreds of practices, manufacturers, and distributors grow through compliant, high-performance marketing strategies. He holds a B.S. in Exercise Physiology and Health Promotion from Florida Atlantic University.
